AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2015
May 19, 2015
30339_dirs_2015-05-19_56b02cb8-4170-49eb-811a-e2e0b6f6446a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-05-18
Reporting Person: Flynn Karen (President, Pharma Pckg Systems)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-05-18 | Common Stock | M | 1909.0000 | $16.0450 | Acquired | 26518.8300 | Direct |
| 2015-05-18 | Common Stock | S | 1909.0000 | $55.0000 | Disposed | 24609.8300 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-05-18 | Stock Option (Right to Buy) | $16.0450 | M | 1909.0000 | Disposed | 2019-02-24 | Common Stock (1909.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 311.7300 | Indirect |
| Common Stock | 1004.2642 | Indirect |
More from WEST PHARMACEUTICAL SERVICES INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 12